THER — Theralink Technologies Balance Sheet
0.000.00%
- $0.62m
- $23.20m
- $0.61m
- 40
- 47
- 16
- 26
Annual balance sheet for Theralink Technologies, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.021 | 1.79 | 0.325 | 0.397 | 0.998 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 0.015 | 0.023 | 0.032 | 0.024 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.062 | 2.07 | 0.639 | 0.647 | 1.26 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.026 | 1.11 | 0.979 | 1.91 | 1.57 |
Other Long Term Assets | |||||
Total Assets | 0.094 | 3.2 | 1.64 | 2.6 | 2.85 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 16 | 1.19 | 3.3 | 3.46 | 39.8 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 16 | 1.5 | 3.58 | 6.4 | 41 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -15.9 | 1.69 | -1.95 | -3.8 | -38.1 |
Total Liabilities & Shareholders' Equity | 0.094 | 3.2 | 1.64 | 2.6 | 2.85 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |